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« Patience et longueur de temps 
Font plus que force ni que rage. » 
− Jean de La Fontaine, Le lion et le rat (1668) 
 
 
 
ABSTRACT 
The central nervous system (CNS) is composed of three major cell types, namely neurons, 
astrocytes and oligodendrocytes that are mainly generated during embryonic stages by 
multipotent neural progenitor cells (NPCs). The decision of a NPC to remain in a self-renewing, 
undifferentiated state, or to commit to neuronal or glial differentiation is guided by the 
combined actions of transcription factors on their downstream target genes. SOX transcription 
factors have been shown to have key roles during neural lineage formation. In this thesis, we 
used several next-generation sequencing approaches to study the molecular mechanisms by 
which SOX transcription factors regulate the maintenance and differentiation of NPCs during 
early neuronal and glial lineage development.  
In Paper I, we investigated how SOX2, SOX3 and SOX11 proteins achieve their distinct 
functions during neuronal lineage development by characterizing their genome-wide binding 
profiles in embryonic stem cells (ESCs), NPCs and neurons. We propose a model of 
sequentially acting SOX proteins during neural lineage formation, whereby SOX proteins pre-
bind large sets of poised silent genes in ESCs and NPCs that are subsequently activated by 
alternative SOX proteins at later stages of neuronal differentiation. 
In Paper II, we examined how chromatin accessibility and transcription factor binding interact 
to regulate the establishment of different gene expression profiles in NPCs originating from the 
developing mouse cortex and spinal cord. We found that despite being ubiquitously expressed 
in all NPCs of the developing CNS, SOX2 regulates the establishment of spatially distinct gene 
expression programs by interacting with region-specific partner factors on a permissive 
chromatin landscape. 
In Paper III, we characterized the genome-wide binding profile of SOX3 in SOX9 in glial 
progenitor cells in order to determine their regulatory roles during the development of 
astrocytes and oligodendrocytes. We show that glial gene expression, similar to neuronal gene 
expression, is regulated by sequentially acting pre-binding SOX proteins. 
Altogether, the results presented in this thesis provide new molecular insights into the 
mechanisms by which SOX proteins achieve their distinct functional roles during neuronal and 
glial lineage development. 
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1 INTRODUCTION 
The central nervous system (CNS) gathers and processes information from the entire body, and 
consists of the brain and the spinal cord. The brain is a remarkable organ that serves as the 
control center of the body. Indeed, as already described by Hippocrates in the 4th century B.C, 
“From the brain alone, arise our pleasures, joys, laughter and jests, as well as our sorrows, 
pains, griefs and tears. Through it, in particular, we think, see, hear and distinguish the ugly 
from the beautiful, the bad from the good, the pleasant from the unpleasant”  (Pandya 2011). 
The spinal cord, on the other hand, carries motor information from the brain to the diverse 
muscles and glands of the body, while also relaying sensory information from the peripheral 
nervous system to the brain. 
The mature CNS contains about 100 billion neurons that mediate the transmission of 
information. Despite their essential function, neurons are outnumbered by glial cells that 
constitute approximately 90% of the cells of CNS. Glial cells, which include oligodendrocytes 
and astrocytes, also perform key functions that are vital for the normal functioning of the CNS. 
Oligodendrocytes form the myelin sheaths that insulate axons and enhance signal transduction, 
whereas astrocytes provide structural support for neurons, participate in the formation of the 
blood-brain barrier, and regulate synaptic transmission (Rowitch 2004; Kessaris et al. 2008). 
The generation of the myriad of differentiated cells that compose the mature CNS mainly 
occurs during embryonic development, and starts with the decision of pluripotent embryonic 
stems cells (ESCs) to become multipotent neural progenitor cells (NPCs) that will in turn 
differentiate into neurons or glial cells. The proper control of gene expression is essential to the 
process of cell differentiation, and largely relies on the activity of transcription factors. 
Members of the SOX transcription factor family have been identified to be key regulators of 
neural lineage formation, and dysregulation of their activities has been implicated in numerous 
diseases, including developmental disorders and cancer. 
In this thesis, we took advantage of the recent advances in next-generation sequencing 
technologies to better understand the molecular mechanisms by which SOX proteins regulate 
the maintenance and differentiation of NPCs during the formation of the CNS. Before 
discussing our findings, I will highlight the importance of the SOX protein family in the 
transcriptional regulation of gene expression. I will also describe their functions during early 
embryogenesis and CNS development, with an emphasis on SOXB, SOXC and SOXE 
proteins. 
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2 THE SOX FAMILY 
2.1 DISCOVERY OF SOX GENES 
In 1990, the Sry gene (Sex-determining region Y) was discovered in both mouse and human 
as being responsible for male sex determination (Gubbay et al. 1990; Sinclair et al. 1990). 
Shortly after this discovery, a number of genes sharing sequence similarities with Sry were 
identified. Sry was therefore the first-identified member of a large gene family that was later 
named the Sox gene family (Sry-related HMG-box) (Gubbay et al. 1990; Denny et al. 1992; 
Wright et al. 1993). 
2.2 CLASSIFICATION OF SOX PROTEINS 
The hallmark of the SOX protein family is the presence of a high-mobility group (HMG) box 
that mediates DNA binding and thereby allows them to act as transcription factors. Members 
of the SOX family exhibit approximately 50% or higher amino acid sequence similarity to 
the HMG box of the founding member of the family, SRY (Bowles et al. 2000).  
SOX proteins are present throughout the animal kingdom, in both invertebrate and vertebrate 
organisms, from Trichoplax adhaerens to human. 20 different SOX proteins have been 
identified in both mouse and human, 27 in zebrafish (Danio rerio), 8 in Drosophila and 5 in 
Caenorhabditis elegans (Bowles et al. 2000). 
SOX proteins have been classified into clearly defined groups, termed A to H in mammals, 
based on the phylogenetic analysis of their HMG domains. The SoxB group was further 
divided into two subgroups, SoxB1 and SoxB2, according to their full-length sequences and 
functional characteristics (Bowles et al. 2000) (Table 1). Members of a same group share at 
least 80% sequence identity within their HMG domain (Wright et al. 1993; Wegner 1999). 
Moreover, the comparison of full-length proteins further revealed that sequence similarities 
extend outside the HMG domain within each group, but not between groups (Wegner 1999; 
Bowles et al. 2000). 
Table 1. Sox groups, their members and their respective transcriptional regulation domain in Mus 
musculus (Kiefer 2007; Guth & Wegner 2008). 
Group Protein Transregulation domain 
SoxA SRY activation 
SoxB1 SOX1, SOX2, SOX3 activation 
SoxB2 SOX 14, SOX21 repression 
SoxC SOX4, SOX11, SOX12 activation 
SoxD SOX5, SOX6, SOX13 none 
SoxE SOX 8, SOX9, SOX10 activation 
SoxF SOX7, SOX17, SOX18 activation 
SoxG SOX15 activation 
SoxH SOX30 activation 
In addition to amino acid sequence similarities, members within a group share similar 
biochemical properties and have consequently been described to have similar biological 
functions (Bowles et al. 2000; Wegner 2010). For instance, the members of the SoxB1 group, 
SOX1-3, have been shown to exert almost identical biological activities in neural stem cells 
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during embryonic development (Wood & Episkopou 1999; Bylund et al. 2003; Graham et al. 
2003). In contrast, members from different groups exhibit distinct functions.  
Furthermore, members of a same group have similar genomic organizations, with members of 
the SoxA, SoxB and SoxC groups containing a single exon (Bowles et al. 2000). However, Sox 
genes are localized randomly throughout the mammalian genome and are not grouped in gene 
clusters (Wegner 1999). 
2.3 EVOLUTIONARY CONSERVATION OF SOX PROTEINS 
Members of the SOX family are highly conserved across species, especially among 
vertebrates where orthologous proteins show a high degree of conservation both within and 
outside their HMG domain. An example is human SOX2 that shares 98% similarity with the 
mouse protein, and 88% with its putative orthologue Dichaete in Drosophila (Bowles et al. 
2000; Pevny & Lovell-Badge 1997). SRY is however an exception to the rest of the SOX 
family as it is poorly conserved outside its HMG domain, even across closely related species, 
and is restricted to mammals (Soullier et al. 1999). Additionally, amino acid sequence 
conservation correlates with conservation of biochemical properties. Ectopic expression of 
the mouse SOX2 in transgenic flies has been shown to rescue the CNS phenotype of Dichaete 
mutants suggesting a functional conservation during evolution (Soriano & Russell 1998). 
2.4 SOX PROTEIN STRUCTURE 
SOX proteins belong to the HMG box-containing protein superfamily that can be divided 
into two subfamilies based on the number of HMG domains they contain. Members of 
SOX/TCF/MATA subfamily have a single HMG domain that binds the DNA in a sequence 
specific manner whereas members of the HMG/UBF subfamily possess multiple HMG 
domains and bind DNA non-specifically (Soullier et al. 1999).  
The HMG domain of SOX proteins contains 79 amino acid residues and consists of three α-
helices and a N-terminal β strand that are arranged in a twisted L-shape (Weiss 2001; Pevny 
& Lovell-Badge 1997). This domain carries out several important functions. It allows for 
precise DNA recognition and binding, bends the DNA, mediates interactions with partner 
proteins, and contains nuclear import or export signals (Wilson & Koopman 2002; Lefebvre 
et al. 2007). 
SOX proteins feature other functional domains. The sequences of most SOX proteins are 
comprised of three main domains: a N-terminal region followed by the HMG domain and a 
C-terminal region (Kamachi & Kondoh 2013; Kamachi et al. 2000). Sequence truncations 
experiments and transactivation assays have shown that the majority of the SOX proteins 
possess a transcriptional regulation domain located in their C-terminal region (Kiefer 2007). 
For most SOX proteins it corresponds to a transactivation domain (Kamachi et al. 1995; 
Südbeck et al. 1996; Kamachi et al. 1998), with the exceptions of SOXB2 proteins, which 
carry a transrepression domain (Uchikawa et al. 1999; Bylund et al. 2003), and of SOXD 
proteins, which reportedly lack transregulation domain (Roose et al. 1998) (Table 1).  
Some SOX proteins additionally contain dimerization domains. Members of the SoxD group 
bear a coiled-coil domain that enables dimerization with members of this group, and SOXE 
proteins have a self-dimerization domain (Kamachi & Kondoh 2013).  
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3 TRANSCRIPTIONAL REGULATION OF GENE 
EXPRESSION BY SOX PROTEINS 
Multicellular organisms contain a wide range of different cell types with distinct functions. 
This great cell diversity is achieved by the establishment of a unique gene expression program 
in each cell type. Gene expression is defined as the complex process “through which a cell 
converts the nucleotide sequence of a gene first into the nucleotide sequence of an RNA 
molecule, and then into the amino acid sequence of a protein”. The regulation of gene 
expression can occur at any step of this process, including transcription, post-transcription 
(RNA splicing), translation, and post-translation (modification of a protein), with transcription 
being the primary mode of regulation (Alberts et al. 2008).  
The transcriptional regulation of gene expression is the result of two main mechanisms. The 
first one involves the combined actions of transcription factors (TFs) and their interacting 
factors on their downstream target gene regulatory regions. The second involves the degree of 
DNA compaction into chromatin, which determines whether a gene regulatory region will be 
accessible or not to TFs and other proteins (Alberts et al. 2008).  
SOX proteins have been suggested to display properties of both classical TFs and architectural 
components of chromatin due to their ability to bend the DNA upon binding (Pevny & Lovell-
Badge 1997). In this chapter, I will describe how SOX proteins bind DNA and act as 
transcriptional regulators of gene expression, on one hand by interacting with partner proteins 
in order to modulate their target gene selection and their activity, and on the other hand by 
influencing the chromatin structure. I will mainly focus on the best characterized SOX protein, 
SOX2, during the development of the CNS. 
3.1 DNA BINDING OF SOX PROTEINS 
Transcription factors are regulatory proteins whose function is to regulate gene expression by 
controlling the transcription of a given gene into a molecule of messenger RNA (mRNA). The 
hallmark of TFs is their DNA binding domain that mediates binding to specific DNA sequences 
within gene regulatory regions, such as promoters and enhancers, in order to activate or repress 
the expression of a gene (Alberts et al. 2008).  
As mentioned previously, SOX proteins contain a HMG domain that mediates binding to the 
DNA, and thus they function as TFs. The optimal DNA-binding motif for SOX TFs was 
identified in vitro using random oligonucleotide selection assays and was defined as 5´-
(A/T)(A/T)CAA(T/A)G -3´ (Harley et al. 1994). More recently, experiments using chromatin-
immunoprecipitation followed by deep sequencing (ChIP-seq) for different SOX TFs have 
further confirmed that this sequence corresponds to the SOX consensus binding motif (Chen 
et al. 2008; Scharer et al. 2009; Hagey & Muhr 2014). In addition, SOX TFs have individual 
preferences for nucleotides flanking this consensus sequence (Mertin et al. 1999). These 
preferences may to some extent explain how SOX TFs achieve their target gene specificity 
despite binding to the same consensus site.  
However, even though all SOX TFs are able to bind a common consensus motif in vitro, 
analysis of SOX bound enhancers in vivo revealed that SOX TFs also bind sequences that only 
partially match the consensus site. During chondrocyte development, SOX5, SOX6 and SOX9 
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were found to bind the SOX consensus motif with one or two mismatches in the examined 
Col2a1 enhancer (Lefebvre et al. 1997; Lefebvre et al. 1998). Therefore, SOX TFs bind DNA 
with little sequence specificity, indicating that other mechanisms may be involved in directing 
SOX TFs to their target genes in vivo. Moreover, it is noteworthy that SOX TFs bind DNA 
with relatively low affinity compared to other TFs, suggesting that their binding alone might 
not be stable enough to induce transcriptional regulation in vivo (Kamachi et al. 2000; Lefebvre 
et al. 2007). 
Another feature of SOX proteins that may have important implications for gene regulation is 
their ability to bend the DNA. While the overall structure of SOX proteins remains unaltered 
upon DNA binding, SOX proteins induce a sharp bend to the DNA they bind to. This bending 
is established by the interaction of the HMG domain with the minor groove, which results in 
the widening of the minor groove and causes the DNA to bend towards the major groove with 
an approximate 80° angle. Thus, unlike most TFs, which bind to the major groove of the DNA, 
SOX proteins are unique in that they interact with the minor groove (Ferrari et al. 1992; Werner 
et al. 1995).  
SOX proteins induce very similar DNA bending angles suggesting that there is no correlation 
between the bending angle and the regulatory potential of distinct SOX proteins (Palasingam 
et al. 2009). Nevertheless, due to their unusual intrinsic bending capacity, it has been speculated 
that SOX proteins may act as architectural proteins by promoting the interaction of distantly 
bound proteins and thereby forming a transcriptional complex (Lefebvre et al. 2007; Pevny & 
Lovell-Badge 1997). Such regulatory function has been described for the HMG protein LEF1 
but remains to be fully uncovered for SOX proteins (Giese et al. 1992).  Evidence supporting 
the importance of the DNA bending ability of SOX proteins come from studies showing that 
SOX mutants that are able to bind but not to bend the DNA result in mutant phenotypes in vivo. 
An example is a de novo mutation that reduces the bending activity of SRY and leads to sex-
reversal in humans, pointing to the possible functional role of SOX DNA bending (Pontiggia 
et al. 1994; Scaffidi & Bianchi 2001). 
3.2 SOX PROTEIN ACTIVITY DEPENDS ON THEIR PARTNERS 
SOX TFs bind a similar DNA binding motif with low specificity and low affinity. Moreover, 
although most SOX TFs contain a transregulation domain, they have been shown to exert weak 
transcriptional activities on their own. As a result, a SOX protein alone might not to be able to 
specifically select its target genes, and its binding might not lead to transcriptional activation 
or repression of gene regulatory regions in vivo. Indeed, SOX TFs have been shown to critically 
depend on their interaction with other proteins in order to be able to exert their gene regulatory 
functions (Kamachi et al. 2000; Lefebvre et al. 2007; Kamachi & Kondoh 2013). 
3.2.1 Partnership with transcription factors  
Studies performing motif analysis in functional enhancers of known SOX target genes showed 
that SOX binding motifs are often in close proximity of other TF motifs. The first described 
example is the Fgf4 enhancer that contains adjacent binding sites for SOX and POU domain 
proteins. SOX2 and OCT4 (also called POU5F1) bind and activate this enhancer in embryonic 
carcinoma cells and embryonic stem cells (ESCs) (Yuan et al. 1995; Ambrosetti et al. 1997). 
Another well characterized example is the DC5 enhancer of the δ-crystalline gene, which 
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features SOX and Paired domain binding sites, and is activated by SOX2 and PAX6 in lens 
cells (Kamachi et al. 1995; Kamachi et al. 2001). In both cases, the SOX protein and its partner 
factor bind cooperatively and in turn activate the enhancer. Mutating either binding site or 
increasing the spacing between the two sites diminishes their cooperative binding and results 
in the complete loss of enhancer activation. Therefore, the functional cooperation of SOX 
proteins with their partners is necessary to stabilize their binding and to elicit the synergistic 
activation of regulatory regions in vivo.  
Furthermore, each SOX protein appears to recognize and regulate distinct sets of target genes 
in different cell types. The interaction of SOX proteins with cell type-specific partner factors 
may thus provide a mechanism of target gene selection in vivo (Kamachi et al. 2000; Lefebvre 
et al. 2007). This is illustrated by the finding that SOX2 acts cooperatively with OCT4 to 
activate the Fgf4 enhancer, but is unable to do so with the related OCT1 protein. This specificity 
offers some insight into how selective gene activation by SOX proteins is achieved (Yuan et 
al. 1995). Additionally, the status of the chromatin, and thus the accessibility to the DNA, may 
also have an important regulatory role in defining SOX target gene selection in different cell 
types, as described later in this chapter. 
Since these pioneer discoveries, SOX proteins have been found to interact with a variety of 
proteins belonging to many TF families (Kondoh & Kamachi 2010) (Paper II). Recently, a 
proteomics analysis was performed in order to identify other putative SOX2 interacting 
proteins in neural progenitor cells (NPCs). In this screen, a total of 50 proteins were found to 
physically interact with SOX2, many of which are known to be involved in neural 
development. Among the 50 proteins constituting the SOX2 interactome, 19 are TFs belonging 
to various families, including the SOX family itself. This confirms that SOX proteins cooperate 
with a multitude of TFs to regulate gene expression and refine their target gene selection 
(Engelen et al. 2011).  
Interestingly, studies have shown that SOX-partner interactions are often mediated by the DNA 
binding HGM domain itself. These interactions can also occur via other domains, such as the 
coiled-coil domain or the C-terminal end of the protein (Wilson & Koopman 2002).  
3.2.2 Partnership with co-regulators 
In addition to TFs, several members of co-activator (TRRAP) and co-repressor (SMRT/NcoR) 
complexes were also identified to be strong partners of SOX2 in NPCs (Engelen et al. 2011). 
Moreover, SOX2 has been suggested to regulate the expression of pluripotency genes in ESCs 
by recruiting the co-activator p300, whose presence is known to predict enhancer activity (Chen 
et al. 2008). SOX2 has also been shown to interact with the repressor Groucho/TLE in NPCs 
to repress the Ccnd1 promoter (Hagey & Muhr 2014). Hence, SOX TFs can modulate their 
transcriptional activity by interacting with either co-activators or co-repressors. This is 
supported by several genome-wide studies where downregulation of SOX2 followed by gene 
expression analysis have demonstrated the dual role of SOX2, which can function as both an 
activator and a repressor of downstream target genes (Engelen et al. 2011; Bergsland et al. 
2011; Hagey & Muhr 2014). This is in contrast with the traditional way of characterizing TFs 
as being either activators or repressors, based on the transregulation domain they carry. 
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In summary, SOX TFs work in a combinatorial fashion and their transcriptional activity 
depends on their interaction with diverse types of partners. 
3.3 SOX PROTEINS AND CHROMATIN 
3.3.1 Chromatin structure 
As mentioned earlier, the modulation of the chromatin structure is another important layer of 
transcriptional regulation of gene expression. Indeed, even when TFs and their partners are 
expressed at the right time and place, the state of chromatin might limit the access to their target 
sequences and thereby impair their transcriptional activity. In order to discuss the possible role 
of SOX TFs in altering chromatin structure, it is necessary to first describe the structure of 
chromatin and how it is regulated. 
The chromatin is a structure that allows the efficient packaging of the entire genome into the 
small cell nucleus. This condensation is achieved by the wrapping of approximately 146 bp of 
DNA around an octamer of core histone proteins made of two copies of H2A, H2B, H3 and 
H4 proteins to create a nucleosome. Arrays of nucleosomes are in turn compacted to form 
chromatin fibers (Kornberg 1977; Venkatesh & Workman 2015). Chromatin exists in two main 
forms: euchromatin, which is loose and permissive for transcription, and heterochromatin, 
which is more condensed and transcriptionally silent (Benayoun et al. 2015). Based on its 
sensitivity to DNase I cleavage, chromatin can further be characterized into regions of “open” 
and “closed” chromatin, which correspond to transcriptionally active and silent gene regulatory 
regions, respectively (Gilbert & Ramsahoye 2005). Regions of open or accessible chromatin 
are thus referred to as DNase I hypersensitivity sites (DHSs) and can be mapped at the genome-
wide level using DNase-sequencing (Natarajan et al. 2012). 
3.3.2 Chromatin remodeling 
Chromatin remodeling corresponds to changes in chromatin compaction that affect the 
accessibility of TFs to their target gene regulatory regions, and that can subsequently lead to 
the altering of gene expression (Venkatesh & Workman 2015). It is a dynamic process that 
plays an essential role during lineage specification and differentiation. Indeed, while the 
chromatin generally becomes more condensed as development proceeds, a substantial number 
of open chromatin regions are also formed de novo (Stergachis et al. 2013; Lara-Astiaso et al. 
2014; Raposo et al. 2015). Accumulating evidence have shown that SOX TFs are engaged in 
some of the mechanisms involved in chromatin remodeling, which will be discussed below.  
ATP-dependent chromatin remodeling enzyme complexes can rearrange nucleosome to create 
regions of accessible DNA for TF binding, which in turn affects gene expression (Wang et al. 
2007; Benayoun et al. 2015). In an aforementioned study (Engelen et al. 2011), several proteins 
of the SOX2 interactome in NPCs were found to belong to chromatin remodeling complexes, 
including the SWI/SNF and NuRD/CHD complexes. In particular, SOX2 interacts very 
strongly with the major chromatin remodeling factor CHD7. This discovery suggests that 
SOX2 may have a role in chromatin remodeling by altering the local chromatin structure 
through the recruitment of components of chromatin remodeling complexes.  
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The post-translational modification of histone protein tails can also adjust chromatin 
accessibility and thus lead to transcriptional activation or repression. There are at least eight 
different types of covalent modifications including methylation, acetylation and 
phosphorylation. Some of the best studied histone modifications correspond to the 
modifications of lysine residues of histone H3, including H3K4me3, which marks active gene 
regulatory regions and H3K27me3, which is a feature of repressed regulatory regions. Thanks 
to the development of ChIP-sequencing technologies, the global distributions of many different 
chromatin modifications have been successful mapped (Kouzarides 2007; Benayoun et al. 
2015).  
SOX2 ChIP-seq experiments in ESCs have revealed that SOX2 binds to regulatory regions of 
active genes involved in pluripotency and self-renewal, and of silent genes that are not 
expressed in ESCs and will be expressed at later stages of development. Interestingly, the gene 
regulatory regions associated to active genes carry the H3K4me3 mark, whereas those 
associated to silent genes that will be expressed later carry the bivalent mark 
H3K4me3/H3K27me3 instead. This bivalent state is believed to keep genes in a permissive 
chromatin state for later activation (Boyer et al. 2006). Strikingly, we have described a similar 
situation where SOX2 in NPCs binds H3K4me3 marked regulatory regions of transcriptionally 
active genes, as well as pre-binds bivalently marked regulatory regions of silent genes involved 
in later stages of neural development (Paper I). It is unclear whether SOX proteins are directly 
involved in regulating the deposition of histone modification marks. Nevertheless, a study 
showed that SOX2 binding contributes to the formation of activating H3K4me2 and H3K4me3 
marks at the λ5-VpreB1 enhancer in ESCs (Liber et al. 2010). In addition, we have shown that 
the ectopic expression of SOX3 in C2C12 mesodermal progenitor cells is followed by 
accumulation of the H3K4me3 mark at SOX3 bound enhancers (Paper I). These two examples 
suggest that SOX proteins may be able to induce local epigenetic changes at bound enhancer 
regions. This is consistent with the fact that SOX2 is a crucial factor in cell reprogramming, as 
chromatin remodeling is essential to this process (Takahashi & Yamanaka 2006; Nakagawa et 
al. 2008).  
3.3.3 Pioneer factors 
Pioneer factors are defined as a specific functional class of TFs that have the ability to bind 
regions of closed chromatin and remodel the chromatin landscape locally to increase target site 
accessibility and thus facilitate the binding of additional TFs. This is in strong contrast to other 
types of TFs that cannot directly bind closed chromatin individually and rely on cooperative 
interactions to access their target sites (Cirillo et al. 2002; Zaret & Carroll 2011). 
In line with this definition, the binding of pioneer factors to chromatin precedes the binding of 
other TFs, and often occurs prior to enhancer activation and gene expression. As an example, 
FOXD3 binds the enhancer of the silent Alb1 liver-specific gene in ESCs and thereby ensures 
the establishment of a permissive chromatin state for subsequent activation by other TFs. 
Indeed, as cells become committed to the endodermal lineage, FOXD3 is replaced by FOXA1, 
which will help activate Alb1 gene expression (Xu et al. 2009). This pre-binding by pioneer 
factors is believed to prime silent enhancers for later activation when cells differentiate, as a 
means to confer rapid transcriptional activation of genes in response to inductive signals.  
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Subsequent to binding, pioneer factors recruit additional TFs that bind to adjacent binding sites 
and in turn contribute to the modulation of gene expression. To enable their binding, pioneer 
factors need to remodel the chromatin landscape locally to increase target site accessibility. 
One important feature of pioneer factors is their capacity to open closed chromatin. To do so, 
pioneer factors can evidently recruit chromatin remodelers to rearrange nucleosomes or 
actively contribute to the establishment of local epigenetic changes at enhancers (Magnani et 
al. 2011). Indeed, in addition to inducing local nucleosome remodeling, the pioneer factor PU.1 
promotes the deposition of the active H3K4me1 mark at enhancers during B cell lineage 
differentiation (Heinz et al. 2010), and FOXA1 promotes of the deposition of the H3K4me2 
mark during neuronal differentiation (Sérandour et al. 2011). 
There is growing body of evidence supporting the idea that SOX2 may function as a pioneer 
factor. Indeed, as mentioned above, SOX2 binding in ESCs and NPCs precedes gene 
activation. It binds enhancers of silent genes that are in a bivalent state, and that will be 
activated by other TFs at a subsequent stage of the differentiation process (Boyer et al. 2006) 
(Paper I). Moreover, SOX2 has been shown to interact with components of multiple chromatin 
remodeling complexes, and appears to be involved in the establishment of chromatin 
modifications at bound enhancers (Liber et al. 2010; Engelen et al. 2011).  
In addition, a study using a single-molecule imaging strategy in order to track the binding 
dynamics of SOX2 and OCT4 in ESCs indicates that SOX2 binds first, and subsequently 
recruits OCT4 to SOX/OCT binding sites. However, this assay did not investigate the influence 
of the chromatin state on this hierarchical binding (Chen et al. 2014). Furthermore, another 
study found that during the reprogramming of fibroblasts, SOX2, OCT4 and KLF4 can on their 
own target regions of closed chromatin that are insensitive to DNase I cleavage and lack active 
chromatin modification marks such as H3K4me3 and H3K27ac. Additionally, c-MYC was 
found to also be able to bind closed chromatin, but only when expressed in the presence of the 
three other factors (Soufi et al. 2012). 
In conclusion, SOX TFs primarily function as classical TFs in order to regulate gene 
expression. With the help of their partner TFs, they bind and regulate distinct sets of genes in 
different cell types. They also recruit diverse types of interacting partners in order to modulate 
gene activity. SOX TFs also have alternative roles of transcriptional regulation, amongst which 
are chromatin remodeling and epigenetic functions. Finally SOX2 appears to have some 
features of pioneer factors in ESCs and NPCs. Hence, SOX proteins are versatile transcriptional 
regulators that employ different modes of action to fulfill their diverse functions. 
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4 SOX PROTEIN FUNCTION DURING EARLY 
EMBRYOGENESIS AND PLURIPOTENCY 
In this chapter, I will present an overview of the roles of SOX proteins during early mouse 
embryogenesis and in pluripotent stem cells, with a focus on SOXB proteins, which play 
essential roles in these processes.  
4.1 PRE-IMPLANTATION DEVELOPMENT 
During mouse embryogenesis, the fertilized egg (oocyte) undergoes a series of rapid cell 
divisions, known as cleavages, resulting in the formation of the morula (E2.5) that further 
develops to form the blastocyst (E3.5). The blastocyst consists of a fluid-filled cavity 
(blastocoel) and two spatially separated cell populations: the inner cell mass (ICM) and the 
outer cells that form the trophoectoderm (TE). Cells of the ICM are pluripotent and will give 
rise to the complete embryo, whereas TE cells will form the extra-embryonic ectoderm and 
generate the placenta (Wennekamp et al. 2013; Zhang & Cui 2014). By the time of uterine 
implantation, the late stage blastocyst (E4.5) already contains three distinct cell lineages: the 
TE and two new cell lineages originating from the ICM. The first of these two new lineages is 
the primitive endoderm, which will develop into extra-embryonic tissues. The second lineage, 
termed epiblast, is pluripotent and will give rise to the embryo proper, which is all the cells in 
the body (Wennekamp et al. 2013; Mihajlović et al. 2015) (Figure 1). 
Figure 1. Overview of mouse pre-implantation development: from fertilized oocyte to blastocyst 
(Wennekamp et al. 2013). 
 
Zygotic SOX2 is first expressed in the ICM and becomes restricted to the epiblast as 
development proceeds (Guth & Wegner 2008; Avilion et al. 2003). The ICM and the epiblast 
are both pluripotent cell populations, which suggests that SOX2 may be involved in the 
formation of early pluripotent embryonic cells. Indeed, zygotic deletion of Sox2 is 
embryonically lethal shortly after implantation, and is the result of a failure to develop an 
epiblast (Avilion et al. 2003). Interestingly, maternal SOX2 expression starts in the oocyte and 
continues throughout pre-implantation development. Therefore, the expression of maternal 
SOX2 could mask an earlier phenotype in zygotic SOX2 mutants (Avilion et al. 2003; 
Keramari et al. 2010). A subsequent study used small interfering RNA (siRNA) to deplete both 
maternal and zygotic Sox2 transcripts, which caused developmental arrest at the morula stage 
and thereby a failure to form a blastocyst (Keramari et al. 2010). These findings demonstrate 
that SOX2 plays critical roles in the formation of the ICM and the epiblast and therefore is an 
essential factor of pluripotency during pre-implantation development.  
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Similarly to SOX2, OCT4 and the homeodomain protein NANOG are also expressed in the 
ICM and epiblast of the developing embryo. Null mutations of either gene lead to embryonic 
lethality due a failure to form the ICM or the epiblast, which indicates that these proteins also 
play important roles in maintaining pluripotency in the early embryo (Nichols et al. 1998; 
Mitsui et al. 2003). 
4.2 EMBRYONIC STEM CELLS 
The first derivation of ESCs from the pre-implantation mouse embryo was reported in 1981 
(Martin 1981; Evans & Kaufman 1981). During the following two decades, ESCs lines were 
derived from a number of mammalian species, including mouse and humans ESCs (mESCs, 
hESCs) (Thomson et al. 1998). ESCs can be derived from the pluripotent ICM or epiblast of a 
blastocyst-stage embryo. Similarly to ICM and epiblast cells, ESCs are pluripotent and can 
give rise to cells from all three embryonic germ layers, namely ectoderm, mesoderm, and 
endoderm. However, while pluripotency is a transient in vivo state that is limited to the 
blastocyst, ESCs grown in culture possess the unique ability to self-renew indefinitely (Plusa 
& Hadjantonakis 2014). Due to these properties, ESCs have been valuable tools to study 
pluripotency and early lineage specification. Importantly, hESCs are believed to hold great 
promise for regenerative medicine and cell-based therapies. However, a better understanding 
of how ESCs identity and differentiation are regulated on the transcriptional level is needed in 
order to realize their full therapeutic potential (Czechanski et al. 2014; Boyer et al. 2005).  
Three TFs, SOX2, OCT4 and NANOG, are highly expressed in ESCs. mESCs cannot be 
derived from the ICM of Sox2-deficient embryos (Avilion et al. 2003). Moreover, deletion of 
Sox2 in already established mESCs severely affects their pluripotency and self-renewal 
capacities as shown by the loss of pluripotency markers and by their differentiation into TE-
like cells. Hence, these findings suggest that SOX2 is required both for the establishment and 
the maintenance of the pluripotent state in mESCs. Interestingly, OCT4 overexpression can 
rescue this phenotype. One possible function of SOX2 in mESCs may thus be to maintain a 
sufficient level of OCT4 expression (Masui et al. 2007).  
Surprisingly, overexpression of SOX2 in mESCs does not lead to a reinforced pluripotent state, 
but instead leads to a loss of self-renewal and triggers their differentiation into multiple cell 
types (Kopp et al. 2008). Indeed, forced expression of SOX2 leads to the downregulation of 
endogenous SOX2 expression. It also downregulates the expression of important embryonic 
target genes of SOX2 such as Nanog (Kopp et al. 2008; Boer et al. 2007). Furthermore, 
modifying OCT4 expression levels in mESCs largely resembles the phenotypes observed with 
SOX2, with a loss of pluripotency and the differentiation of these cells, although towards 
different lineages (Nichols et al. 1998). Conversely, overexpression of NANOG in mESCs 
maintains their self-renewal capacities (Chambers et al. 2003). All together, these results 
demonstrate that the precise control of SOX2, OCT4 and NANOG expression levels is critical 
to maintaining pluripotency and self-renewal in ESCs. 
A number of genome-wide binding studies have been performed in order to identify the 
downstream target genes of SOX2, OCT4 and NANOG as a means to better understand how 
they achieve their regulatory functions in ESCs. ChIP experiments combined with microarray 
(ChIP-on-Chip) or ChIP-seq experiments revealed that these factors bind to both promoters 
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and distal enhancers of thousands of genes in ESCs.  It also showed that they co-bind a large 
number of target genes that they functionally regulate. Indeed, about half of the promoters 
bound by OCT4 are also bound by SOX2 in hESCs, and almost all of these promoters are 
additionally bound by NANOG. Many of their shared target genes are active in hESCs and 
encode TFs and components of signaling pathways known to be involved in pluripotency and 
self-renewal. Notably, they bind to the promoter of their own gene, forming auto regulatory 
loops in order to stabilize their own expression. Interestingly, these three factors also occupy 
genes that are inactive in hESCs and that are enriched for TFs implicated in various 
developmental processes such as PAX6, HOXB1 and LHX5 (Boyer et al. 2005; Chen et al. 
2008; J. Kim et al. 2008). Thus, SOX2, OCT4 and NANOG bind and activate the expression 
of pluripotency genes in order to keep ESCs undifferentiated, while also occupying key 
developmental genes.  
Collectively, functional experiments as well as genome-wide binding data in ESCs demonstrate 
the existence of a core transcriptional regulatory network in ESCs that is necessary to sustain 
the ESC state and consists of three TFs: SOX2, OCT4 and NANOG. 
4.3 INDUCED PLURIPOTENT STEM CELLS 
The importance of SOX2 in establishing and maintaining pluripotency was further confirmed 
with the fascinating discovery that somatic cells can be  reprogrammed into ESC-like cells 
(Takahashi & Yamanaka 2006). Only five years after the publication of this groundbreaking 
work, Shinya Yamanaka was awarded the Nobel Prize in Physiology or Medicine.  
The so-called induced pluripotent stem cells (iPSCs) were initially generated by the 
transduction of a cocktail of four TF genes that are important for pluripotency in ESCs, namely 
Sox2, Oct4, Klf4 and c-Myc (Takahashi & Yamanaka 2006; Takahashi et al. 2007). iPSCs are 
similar to ESCs in that they are pluripotent cells capable of long-term self-renewal. They have 
been generated from various somatic cell types including mouse embryonic fibroblasts, adult 
mouse and human fibroblasts, and adult mouse neural stem cells (Takahashi & Yamanaka 
2006; Takahashi et al. 2007; J. B. Kim et al. 2008).  
Further studies have demonstrated that the other members of the SoxB1 group, SOX1 and 
SOX3, can substitute for SOX2 to generate iPSCs, but that other members of the SOX family, 
like SOX7 and SOX15, cannot (Nakagawa et al. 2008). Moreover, while SOX2 and OCT4 are 
sufficient for the reprogramming process, KLF4 and C-MYC are dispensable factors that can 
nevertheless be used to improve reprogramming efficiency (Huangfu et al. 2008; Nakagawa et 
al. 2008). SOX2 is thus essential for the efficacious reprogramming of somatic cells into iPSCs, 
and its physical interaction with OCT4 may have central to this process.  
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5 SOX PROTEIN FUNCTION DURING CENTRAL 
NERVOUS SYSTEM DEVELOPMENT 
How a common pool of cells can generate all the differentiated cell types that compose the 
CNS is a fundamental question in developmental biology. In this chapter, I will highlight the 
functions of the SOX proteins involved in controlling cell proliferation and their differentiation 
into neurons and glial cells, in particular those of the SoxB, SoxC and SoxE groups, which are 
of relevance to the work presented in this thesis. I will mainly focus on the functions they exert 
in cells of the developing vertebrate spinal cord.  
5.1 NEURAL TUBE DEVELOPMENT 
Shortly after implantation of the blastula in the uterus, a complex and coordinated cell 
reorganization occurs, whereby cells of the epiblast migrate through a structure called the 
primitive streak, and move toward the inside of the blastula. This process, known as 
gastrulation (E6.5), gives rise to all three primary germ layers and establishes the major body 
axes of the embryo. Through a developmental process called organogenesis, each germ layer 
of the embryo will later differentiate and develop into specific tissues and organs. The 
endoderm will thus form the lining of the digestive and respiratory systems, while the 
mesoderm will form the bones, cartilages, muscles as well as some internal organs. The 
ectoderm becomes, upon neural induction, subdivided into the neuroectoderm, which will later 
give rise to the nervous system, and the non-neural ectoderm, which will form to the epidermis 
(Sanes et al. 2011; Wolpert 2002).  
Soon after the formation of the neuroectoderm begins another fundamental embryonic event 
called neurulation, which leads to the formation of the neural tube. Induced by the mesoderm, 
neurulation corresponds to a sequence of steps that start with the thickening of the 
neuroectoderm and the elevation of the neural plate borders, causing the neural plate to fold 
onto itself and close, thereby creating the neural tube (E8.5-E10.5). 
SOX2 and SOX3, which are both expressed in the epiblast of the blastula, become restricted to 
cells of the ectoderm during gastrulation (Wood & Episkopou 1999; Avilion et al. 2003). By 
E7.5, their expression is further confined to the neuroectoderm, where the third member of the 
SoxB1 group, SOX1, is additionally turned on (Wood & Episkopou 1999; Avilion et al. 2003). 
The continuous restriction of SOXB1 expression in cells fated to become part of the CNS points 
to their potential role in the neural commitment of the embryonic ectoderm. This is evidenced 
by studies in Xenopus laevis where the ectopic expression of Sox2 or the injection of dominant 
negative forms of Sox2 showed that Sox2 is required for the differentiation of the ectoderm into 
the neuroectoderm (Kishi et al. 2000). Similarly, overexpression of either SOX1 or SOX2 in 
ESCs under culture conditions that do not support self-renewal promotes their differentiation 
into the neuroectodermal lineage at the expense of the mesodermal and endodermal fates (Zhao 
et al. 2004). Furthermore, recent studies have shown that SOX2, OCT4 and NANOG, which 
are crucial to maintaining pluripotency, also act as lineage specifiers, with SOX2 promoting 
ESC differentiation towards neuroectoderm, and OCT4 and Nanog towards mesendoderm 
(Loh & Lim 2011; Thomson et al. 2011). Taken together, these results highlight the role of 
SOXB1 proteins in early neural lineage commitment in the embryo and in ESCs. 
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All three SOXB1 proteins are expressed in a highly overlapping and conserved manner in the 
developing neuroectoderm of many species, such as in chicken, mouse, and human (Wood & 
Episkopou 1999; Collignon et al. 1996). Given the aforementioned results and their co-
expression pattern, it is likely that SOXB1 proteins might function redundantly. This 
assumption is supported by the phenotypes of Sox1 and Sox3 knockout mice as well as Sox2 
hypomorphic mouse mutants (whose SOX2 expression level is lower), which surprisingly 
display relatively normal neuroectoderm formation and development, and therefore suggest 
that SOXB1 proteins might compensate for the loss of each other (Nishiguchi et al. 1998; 
Rizzoti et al. 2004; Ferri et al. 2004). However, genetic studies in which members of the SoxB1 
group have been deleted in a combinatorial fashion have not yet been reported. 
As development proceeds, the neural tube will evolve into the central nervous system, with the 
anterior part of the neural tube giving rise to the three primary brain vesicles (forebrain, 
midbrain and hindbrain), and the posterior part generating the spinal cord (Sanes et al. 2011; 
Wolpert 2002). The developing neural tube consists of neuroepithelial cells which are self-
renewing multipotent NPCs lining the brain ventricles and the spinal central canal. These 
progenitor cells generate all the differentiated neural cell types that will constitute the mature 
CNS, by giving rise to neurons first and glial cells later  (Reiprich & Wegner 2015). In the 
developing spinal cord, the transition from a proliferative progenitor cell to a postmitotic neural 
cell can be visualized. Indeed, the different cellular stages of this multiple step process are 
spatially organized into three distinct cell layers that are characterized by the expression of 
specific marker genes. The dividing NPCs are located in the innermost layer of the developing 
spinal cord called the ventricular zone (VZ). Upon differentiation, NPCs exit the cell cycle and 
migrate laterally to the intermediate zone. Finally, differentiating cells settle in the outer 
marginal zone. Each step is tightly controlled by TFs that coordinate the expression of specific 
sets genes in order to regulate neural cell fate specification and differentiation (Diez del Corral 
& Storey 2001; Kintner 2002) (Figure 2). 
Figure 2. Cross-section of the developing spinal cord illustrating a layered organization characterized 
by the expression of specific markers genes (Diez del Corral & Storey 2001).  
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5.2 NEURONAL DEVELOPMENT  
5.2.1 Neuronal progenitor cells maintenance 
After neural tube formation, SOXB1 proteins continue to be expressed along the antero-
posterior (A/P) axis of the developing neural tube (Collignon et al. 1996). With the onset of 
neurogenesis, the process by which a NPC differentiates to form a mature neuron, their 
expressing becomes restricted to the proliferating NPCs residing in the VZ of the developing 
CNS. Indeed, as cells differentiate, the expression of SOXB1 proteins is rapidly downregulated 
(Bylund et al. 2003; Graham et al. 2003). 
Key misexpression experiments in the chicken neural tube have provided a better 
understanding of SOXB1 functions during early CNS development. Forced expression of 
either SOXB1 proteins using in ovo electroporation effectively keeps NPCs in a proliferative 
state and inhibits neuronal differentiation. Conversely, inhibition of their activity hinders self-
renewal and proliferation, promotes premature exit from the cell cycle and induces neuronal 
differentiation, as evidenced by the precocious expression of neural differentiation markers 
(Bylund et al. 2003; Graham et al. 2003). Moreover, the finding that the three SOXB1 proteins 
produce the same effect indicates that they function redundantly in NPCs.  
The differentiation of NPCs into neurons is dependent on the activity of proneural basic Helix-
Loop-Helix (bHLH) proteins, such as NGN2. In NPCs, the expression of proneural bHLH 
proteins is maintained at a low level through active Notch signalling (Bertrand et al. 2002; 
Nakada et al. 2004). Interestingly, although Notch signalling can block NPCs differentiation, 
the maintenance of NPCs in an undifferentiated state still requires the activity of SOXB1 
proteins (Holmberg et al. 2008). Indeed, forced expression of SOXB1 proteins block the 
activity of proneural bHLH proteins in NPCs. Conversely, the ability of proneural bHLH 
proteins to promote neural differentiation is partly dependent on its ability to downregulate 
SOXB1 expression in NPCs (Bylund et al. 2003). However, how SOXB1 and proneural bHLH 
proteins regulate each other’s activity and expression is not fully understood. 
Because deletion of Sox2 is embryonically lethal, several studies have used conditional knock-
out approaches to investigate the role of SOX2 in the developing mouse CNS. In a first study, 
the conditional neural-specific deletion of Sox2 using a Nestin-Cre transgene is lethal at birth 
and only causes minor brain defects such as enlarged ventricles. Interestingly, a reduced 
number of progenitors was observed at E14.5, suggesting that SOX2 might be involved in the 
maintenance of NPCs in the developing brain (Miyagi et al. 2008). A second study also used a 
Nestin-Cre transgene to effectively delete Sox2 from E12.5. Although only small brain defects 
can be detected, a complete loss of NPCs and neurogenesis is observed in the hippocampus of 
mutant mice one week after birth. This study additionally assessed the effect of the loss of Sox2 
in vitro, in NPCs cultured as neurospheres. In the absence of Sox2, the sphere formation 
capacity is progressively lost, cell death is increased, cell proliferation is decreased, and the 
neuronal marker TUJ1 is concomitantly expressed (Favaro et al. 2009). Consequently, Sox2 
plays a pivotal role in the maintenance of NPCs, both in vivo and in vitro. 
In addition to being expressed from the earliest stages of the developing CNS, SOXB1 
expression persists in NPCs of neurogenic niches in the adult brain, that is the subventricular 
zone of the lateral ventricles and the subgranular zone of the dentate gyrus of the hippocampus 
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(Ellis et al. 2004; Ferri et al. 2004; Wang et al. 2006). Reduction of Sox2 expression in the adult 
mouse brain of Sox2 hypomorphic mutants leads to a significant decrease in NPCs proliferation 
and an impaired adult neurogenesis. Therefore, in analogy with SOX2 function in embryonic 
NPCs, SOX2 maintains cells as proliferative progenitors in the adult brain (Ferri et al. 2004). 
Interestingly, the finding that adult Sox2-deficient mice exhibit defects in neural differentiation 
suggests that apart from maintaining NPCs undifferentiated, Sox2 might also be required for 
the generation of subsets of neurons (Ferri et al. 2004). 
Moreover, ectopic expression of SOX2 alone or together with other TFs was shown to directly 
reprogram fibroblasts into multipotent self-renewing induced NPCs without passing through a 
pluripotent state, which further supports the importance of SOX2 in NPCs (Han et al. 2012; 
Ring et al. 2012).  
The global binding pattern of SOXB1 proteins, in particular that of SOX2, has been extensively 
studied in NPCs, both derived from mESCs and isolated from mouse embryonic tissues 
(Engelen et al. 2011; Lodato et al. 2013; Hagey & Muhr 2014) (Paper I, Paper II). These 
ChIP-seq experiments have revealed that SOX2 binds thousands of genes, many of which are 
expressed in NPCs and are known to be important for NPCs maintenance. However, SOX2 
also binds genes that are not yet expressed in NPCs and that will be expressed at later stages of 
neural development, which will be discussed later in this thesis.  
In summary, SOXB1 proteins are essential for the maintenance of NPC properties in the 
developing and adult CNS. 
5.2.2 Neuronal differentiation 
SOX21, a member of the SoxB2 subgroup exhibiting trans-repression activity, is co-expressed 
with SOXB1 proteins in NPCs of the developing and adult CNS (Rex et al. 1997; Uchikawa et 
al. 1999; Matsuda et al. 2012). However, SOX21 has the opposite function compared to 
SOXB1 proteins and promotes neural differentiation. Indeed, ectopic expression of SOX21 in 
the chicken neural tube induces NPCs to downregulate progenitor makers, exit the cell cycle 
and express neuronal makers. It appears that the precise balance between SOX21 and SOXB1 
proteins influences whether cells will remain as progenitors or undergo neurogenesis, and it is 
thought that they might compete for binding to the same target genes. Interestingly, the ability 
of proneural proteins to repress SOXB1 proteins in NPCs, and thereby to promote neuronal 
differentiation, depends on their capacity to influence this balance by upregulating SOX21 
expression (Sandberg et al. 2005). Furthermore, SOX21 was reported to regulated hippocampal 
adult neurogenesis by repressing the Notch-responsive gene Hes5 (Matsuda et al. 2012). 
The differentiation of NPCs into neurons is characterized by the switch from SOXB1 and 
SOXB2 proteins to the expression of SOXC proteins, which consist of SOX4, SOX11 and 
SOX12. Thus, as NPCs exit the cell cycle and migrate away from the VZ, SOXB1 and SOXB2 
are downregulated and SOXC proteins start to be expressed. SOXC proteins show overlapping 
expression in postmitotic neural cells committed to neuronal differentiation, where they are 
responsible for the establishment of pan-neuronal characteristics (Bergsland et al. 2006). 
Indeed, ectopic expression of SOX4 or SOX11 in NPCs of the chicken neural tube induces the 
precocious expression of pan-neuronal genes such as Tubb3 and Map2. Unexpectedly, these 
cells remain in the cell cycle and continue to express SOXB1 proteins, and therefore do not 
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differentiate per se. Importantly, the ability of proneural bHLH proteins to induce neuronal 
differentiation relies on the activity of SOXC proteins, their downstream effector (Bergsland 
et al. 2006). Hence, the activation of pan-neuronal genes by SOXC proteins is an important 
step towards the formation of a differentiated neuron, and appears to be independent of cell 
cycle exit. 
In addition to the CNS, SOXC proteins are expressed in numerous other tissues during mouse 
development. Consequently, mice deficient for Sox4 or Sox11 display multiple organ defects, 
which hints to their role in organogenesis (Schilham et al. 1996; Sock et al. 2004; Bhattaram 
et al. 2010). Sox12-deficient mice however develop normally despite its widespread expression 
(Hoser et al. 2008). Nevertheless, while Sox4 and Sox11 double knockout embryos die at E10.5, 
the additional inactivation of Sox12 worsens this phenotype and embryos die earlier, at E8.5, 
indicating that these three genes function in redundancy in multiple developmental processes 
(Bhattaram et al. 2010). With regard to the CNS, the neural-specific deletion of both Sox4 and 
Sox11 using a Brn4-Cre transgene results in a strong increase in cell death, demonstrating the 
requirement of Sox4 and Sox11 for cell survival in the developing mouse neural tube (Thein et 
al. 2010; Bhattaram et al. 2010).  
SOXC proteins are transiently expressed in neuronal cells and are downregulated as 
development proceeds. However, SOXC proteins continue to be highly expressed in 
neurogenic niches of the adult mouse brain. In the dentate gyrus of the hippocampus, the 
expression of SOX4 sand SOX11 is initiated in committed neuronal cells and coincides with 
the downregulation of SOX2 and the onset of neuronal markers expression. Their expression 
is maintained in immature neurons but is eventually downregulated in mature neurons 
(Haslinger et al. 2009; Mu et al. 2012). Overexpression of either SOX4 or SOX11 in adult 
hippocampus-derived NPCs is sufficient to induce the expression of neuronal markers such as 
DCX and TUJ1, despite culture conditions promoting proliferation. Conversely, NPCs in 
which Sox4 and Sox11 were ablated exhibit a reduced expression of the aforementioned 
neuron-specific proteins. Consistent with these in vitro experiments, NPCs in the hippocampus 
of Sox4 and Sox11 double conditional knockout mice have a decreased expression of neuronal 
markers, and instead maintain SOX2 expression. However, in contrast to the phenotype 
observed during embryonic development, deletion Sox4 and Sox11 does not appear to affect 
cell survival in the adult brain. Together, these gain and loss-of-function experiments 
demonstrate that SOX4 and SOX11 are essential regulators of neuronal fate commitment in 
the adult hippocampus (Mu et al. 2012), which is reminiscent of their role in the developing 
chicken neural tube (Bergsland et al. 2006). 
Strikingly, ChIP-seq experiments have shown that despite having opposite functions during 
neural development, the binding patterns of SOX2 and SOX3 in NPCs and of SOX11 in early 
neurons overlap greatly (Paper I). 
Interestingly, in addition to regulating the early steps of neurogenesis, SOXB1 proteins also 
function in subsets of postmitotic neurons in the adult mouse brain. Indeed, while SOXB1 
proteins are normally downregulated upon cell cycle exit, they are maintained or re-expressed 
in specific and mostly non overlapping populations of differentiated neurons where they exert 
distinct functions, including cell differentiation and migration (Malas et al. 2003; Rizzoti et al. 
2004; Ferri et al. 2004; Ekonomou et al. 2005).  
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In conclusion, these studies demonstrate that neuronal development relies on multiple SOX 
proteins that have distinct functions, with SOXB1 maintaining NPCs undifferentiated, and 
SOX21 and SOXC proteins promoting neuronal differentiation. 
5.3 GLIAL DEVELOPMENT 
5.3.1 Spinal cord patterning and glial specification 
As mentioned previously, the vast majority of neuronal and glial cell types that constitute the 
mature CNS are produced during embryonic stages by multipotent NPCs residing in the VZ of 
the developing neural tube. Along the dorso-ventral axis of the embryonic spinal cord, the VZ 
is actually divided into distinct regionally-restricted progenitor domains that will each give rise 
to a specific neuronal cell type. For instance, in the ventral spinal cord, NPCs of the pMN 
domain will generate motor neurons, while NPCs of the p0-p3 domains will produce different 
subtypes of interneurons (Rowitch 2004; Kessaris et al. 2008). The patterning of the developing 
spinal cord into distinct progenitor domains is mediated ventrally by the concentration gradient 
of sonic hedgehog (SHH) and dorsally by the gradient of bone morphogenetic proteins (BMPs), 
which are secreted by the floor plate and the roof plate, respectively. These signaling molecules 
control the expression of sets of TFs that are spatially restricted to a particular progenitor 
domain. These TFs in turn regulate distinct downstream target genes in order to establish 
unique NPCs identities and consequently generate specific neuronal cell types (Rowitch 2004; 
Kessaris et al. 2008) (Figure 3). 
During development, multipotent NPCs first give rise to 
neurons, followed by astrocytes and oligodendrocytes. 
They do so by transitioning from a neurogenic to a 
gliogenic potential (Kiefer 2007). The so-called neuron to 
glia switch predominantly takes place in two of the ventral 
progenitor domains of the developing spinal cord, the 
pMN and the p2 domains, wherein the vast majority of 
glial cells are generated (Richardson et al. 2006). NPCs of 
the p2 domain first generate V2 interneurons and later 
switch competence to give rise to astrocytes. By contrast, 
NPCs of the pMN domain, which are characterized by the 
expression of the transcription factor OLIG2, produce 
motor neurons first and then oligodendrocytes (Kessaris et 
al. 2001; Zhou & Anderson 2002). 
It is well established that SOX9, a member of the SoxE 
group, is a major regulator of this competence switch. In 
NPCs of the mouse spinal cord, SOX9 starts to be 
expressed ventrally at E9.5 and is then expressed 
throughout the VZ by E10.5 where its expression strongly 
overlaps that of SOXB1 proteins (Scott et al. 2010). SOX9 expression continues in 
proliferating, migrating oligodendrocyte progenitor cells (OPCs) and is downregulated in 
differentiating, myelin-forming oligodendrocytes. On the other hand, SOX9 expression is 
maintained in astrocytes until adulthood. Conditional deletion of Sox9 using a Nestin-Cre 
Figure 3. Patterning of the ventral 
embryonic spinal cord into distinct 
progenitor domains. Pink dots: SHH 
concentration gradient; RP: roof plate; 
FP: floor plate (Rowitch 2004) 
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transgene is characterized by the dramatic reduction in oligodendrocyte and astrocyte 
progenitor cells, coupled with an increased number of motorneurons and V2 interneurons. The 
extended period of neurogenesis together with the delayed gliogenesis point to a neuron to glia 
switch defect (Stolt et al. 2003). Hence, SOX9 is required for both oligodendrocyte and 
astrocyte fate specification in the developing mouse spinal cord. 
Two members of the nuclear factor I (NFI) family of transcription factors, NFIA and NFIB, 
start to be expressed in the developing mouse spinal cord at E11.5, at the time when gliogenesis 
is initiated. These factors have been shown to be both necessary and sufficient to promote glial 
fate specification in vivo, and are thus key regulators of the neuron to glia switch (Deneen et 
al. 2006). Importantly, a later study has demonstrated that the expression of NFIA is directly 
regulated by SOX9 (Kang et al. 2012). Hence, SOX9 appears to initiate the neuron to glia 
switch by activating NFIA which in turn induces gliogenesis. 
Although severely affected, the specification of oligodendrocytes cells is not completely lost 
in the absence of Sox9 (Stolt et al. 2003). Interestingly, SOX8, another member of the SoxE 
group, is induced in ventral NPCs shortly after SOX9 (E11), is expressed along with SOX9 in 
proliferating OPCs, and in contrast to SOX9 is maintained in mature, terminally differentiated 
oligodendrocytes (Stolt et al. 2004; Stolt et al. 2005). Even though deletion of Sox8 alone does 
not impair oligodendrocyte specification by itself (Sock et al. 2001), the combined loss of Sox8 
and Sox9 leads to a more severe specification defect defined by the complete absence of 
oligodendrocytes (Stolt et al. 2005). These results suggest that SOX8 and SOX9 function 
redundantly to control glial specification. 
5.3.2 Oligodendrocyte development 
The generation of neurons and glial cells are multi-step processes that include specification, 
migration and differentiation. Unlike neurons, which become post-mitotic and start migrating 
away from the VZ shortly after being specified, glial cells do not immediately exit the cell cycle 
after their specification, and instead migrate throughout the CNS as proliferative progenitor 
cells before settling to become post-mitotic, differentiated cells (Kessaris et al. 2008). A 
number of SOX proteins have been identified to be expressed at different phases of 
oligodendrocyte development in the mouse spinal cord, and their respective roles have been 
uncovered thanks to the use of genetic studies, as presented below. 
The third member of the SoxE group, SOX10, is selectively expressed in oligodendrocytes and 
is thus one of the key markers of the oligodendrocyte lineage (Stolt et al. 2002). Its expression 
is initiated upon glial specification (E11.5) in proliferating OPCs in the pMN domain of the 
ventral VZ. SOX10 is co-expressed with SOX8 and SOX9 in migrating, proliferating OPCs 
(Stolt et al. 2002; Stolt et al. 2003; Stolt et al. 2005). In analogy with SOX8, SOX10 expression 
persists in oligodendrocytes as they settle in the marginal zone of the developing spinal cord 
and undergo terminal differentiation (E18.5) (Stolt et al. 2002; Zhou & Anderson 2002; Stolt 
et al. 2003; Stolt et al. 2004; Stolt et al. 2005).  
Deletion of Sox10 does not affect the number, appearance or distribution of OPCs in the mouse 
embryonic spinal cord (Stolt et al. 2002). In a similar way, the selective ablation of Sox9 in 
already specified OPCs using a Sox10-Cre transgene does not affect oligodendrocyte 
development (Finzsch et al. 2008). Considering that all three members of the SoxE group are 
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co-expressed once OPCs are specified, the observed lack of OPCs defect is likely due to the 
fact that SOXE proteins compensate for the loss of one another in proliferating OPCs. This 
assumption is supported by the combined deletion of Sox9 and Sox10 following OPCs 
specification. In this study, the number of OPCs is significantly reduced due to an increased 
apoptosis, and their migration pattern is altered. These results demonstrate that SOX9 and 
SOX10 function in a redundant manner during the time window when they are co-expressed, 
and are required for  OPCs survival and migration during oligodendrocyte lineage progression 
(Finzsch et al. 2008).  
Unlike SOX9, whose expression ends when OPCs start to differentiate, SOX8 and SOX10 are 
maintained throughout the maturation phase of oligodendrocyte development. SOX10 
expression is even increased with the onset of terminal differentiation (Stolt et al. 2002; Stolt 
et al. 2003; Stolt et al. 2005). It is therefore not surprising that SOX10 plays a crucial role in 
the final step of oligodendrocytes development. Indeed, while proliferating OPCs are not 
affected by the ablation of Sox10 alone, the terminal differentiation of oligodendrocytes is in 
contrast profoundly impaired. OPCs fail to undergo terminal differentiation as illustrated by 
the absence of myelin gene expression such as myelin basic protein (Mbp) and myelin 
proteolipid protein (Plp). As a consequence, Sox10-deficient mice display severe myelination 
defects and die around the time of birth (Stolt et al. 2002). These results therefore indicate that 
SOX10 is required for terminal differentiation of oligodendrocytes. Nevertheless, the 
expression of myelin genes is not completely abolished in the absence of Sox10 (Stolt et al. 
2002). The lack of complete penetrance may be due to the overlapping expression of SOX8 
during the phase of terminal differentiation. Indeed, SOX8 has been shown to partially 
compensate for the loss of SOX10 during oligodendrocyte differentiation (Stolt et al. 2004; 
Kellerer et al. 2006). 
ChIP experiments followed by polymerase chain reaction (PCR) have demonstrated that 
SOX10 binds to the Mbp promoter, suggesting that SOX10 directly controls the expression of 
myelin genes (Stolt et al. 2006). Accordingly, a recent study investigating the genomic 
occupancy of SOX10 in oligodendrocytes from postnatal rat spinal cords demonstrated that 
SOX10 binds many regulatory regions of genes critical for myelination (Lopez-Anido et al. 
2015). 
Furthermore, SOX10 can be used together with other TFs for the direct reprogramming of 
mouse embryonic fibroblasts into induced OPCs capable of giving rise to myelinating 
oligodendrocytes, which further supports the central role of SOX10 during oligodendrocyte 
development (Najm et al. 2013; Yang et al. 2013). 
The temporal control of oligodendrocyte development is also regulated by the SOXD proteins 
SOX5 and SOX6. Their expression is initiated in the VZ of the spinal cord at E10.5, shortly 
before the onset of oligodendrocyte specification. SOX5 and SOX6 expression pattern is 
similar to that of SOX9 as they are maintained in proliferating OPCs but are downregulated 
prior to terminal differentiation. Genetic studies have revealed that SOX5 and SOX6 control 
several stages of oligodendrocyte development in a redundant manner. In mice deficient for 
Sox5 and Sox6, specification of OPCs occurs earlier and oligodendrocytes differentiate 
prematurely (Stolt et al. 2006). Hence, SOX5 and SOX6 are involved in repressing 
oligodendrocyte specification and terminal differentiation. Therefore, they exert opposite 
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functions to SOX9 and SOX10, which promote oligodendrocyte specification and terminal 
differentiation, respectively (Stolt et al. 2002; Stolt et al. 2003; Stolt et al. 2006). As for the 
mechanism, it appears that SOXD proteins directly counteract SOX10 function by competing 
for the same binding sites in myelin genes, such as the Mbp promoter, which likely prevents 
their activation by SOX10. Once SOXD proteins are downregulated, SOX10 can finally 
activate myelin genes and regulate terminal differentiation (Stolt et al. 2006).   
In summary, SOX proteins have key roles at each step of oligodendrocyte development. How 
does a particular SOX protein perform distinct functions at different stages of oligodendrocytes 
development is not well understood. Getting a better picture of their respective downstream 
target genes at different stages of development would certainly help better understand how they 
exert their function.  
5.3.3 Astrocyte development 
Although astrocytes are the most abundant cell type in the CNS, they were until recently 
considered to mainly serve as metabolic support to neurons, and therefore have been far less 
studied than neurons and oligodendrocytes. Consequently, while the functions of the SOX 
proteins expressed in the neuronal and oligodendrocyte lineages have largely been elucidated, 
much less is known about the roles of SOX proteins during astrocyte development. With the 
growing understanding that astrocytes play active roles in CNS development and diseases, it is 
crucial to better understand the molecular mechanisms regulating their specification and 
differentiation (Molofsky & Deneen 2015).  
One of the key factors of astrocyte development is SOX9, the only member of the SoxE group 
to be expressed in the astrocyte lineage. While SOX9 is selectively downregulated in the 
oligodendrocyte lineage with the onset of terminal differentiation, it is expressed in all phases 
of astrocyte development and continues to be expressed in the adult. This suggests that SOX9 
probably has roles beyond astrocyte specification, and might be important at later stages of 
astrocyte development (Stolt et al. 2003). 
As already discussed, an important function of SOX9 is to induce the expression of NFIA, a 
key factor of the neuron to glia switch. Following its induction, NFIA physically interacts with 
SOX9 to bind and regulate common target genes with migration and metabolic roles in 
astrocytes, as supported by ChIP-PCR experiments (Deneen et al. 2006; Kang et al. 2012). The 
importance of these factors in astrocyte development is further highlighted by the finding that 
the ectopic expression of SOX9, NFIA and NFIB can direct the conversion of mouse 
embryonic fibroblasts into astrocytes (Caiazzo et al. 2015). However, revealing the binding 
pattern of SOX9 through ChIP-seq experiments would greatly help gain new insights into the 
role of SOX9 during astrocyte development (Paper III). 
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6 AIMS 
The aim of this thesis is to unravel novel insights into the mechanisms regulating the 
maintenance and differentiation of neural progenitor cells at the transcriptional level. 
More specifically, we aim to: 
I. Characterize the genome-wide binding profiles of SOXB1 and SOXC proteins to examine 
their sequential roles during neuronal differentiation. 
II. Examine how chromatin accessibility and transcription factor binding interact to regulate 
the establishment of gene expression in neural progenitor cells. 
III. Characterize the genome-wide binding profile of SOX3 and SOX9 in glial progenitor cells 
in order to determine their regulatory roles during the development of astrocytes and 
oligodendrocytes. 
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7 RESULTS 
7.1 PAPER I 
Sequentially acting Sox transcription factors in neural lineage development  
The generation of neurons from stem cells depends on several different SOX proteins, from 
early neural lineage specification in ESCs to later stages of neuronal differentiation. SOX2 is 
essential for the establishment and maintenance of ESCs (Avilion et al. 2003), SOXB1 proteins 
maintain NPCs undifferentiated (Bylund et al. 2003; Graham et al. 2003), and SOXC proteins 
are important for the induction of neuronal characteristics (Bergsland et al. 2006). In order to 
understand how different groups of SOX proteins functionally achieve their distinct activities, 
we have used ChIP-sequencing to identify their downstream target genes during neural lineage 
formation. We have determined the genome-wide binding profiles of SOX2/SOX3 and SOX11 
in mESCs-derived NPCs and immature neurons, respectively, and compared them to the 
previously identified binding profile of SOX2 in mESCs (Chen et al. 2008). 
The analysis of the ChIP-seq experiments in NPCs revealed that SOX3 binds more than 9000 
binding sites, which corresponds to approximately 4000 different target genes, as a given gene 
can be associated with several binding sites. Interestingly, consistent with the redundant 
functions of SOXB1 proteins in NPCs, the binding pattern of SOX2 and SOX3 largely 
overlapped, as 96% of the sites targeted by SOX2 are co-occupied by SOX3. Moreover, in 
contrast to another study, which found that SOX2 primarily binds to promoters (Engelen et al. 
2011), we found that most regions bound by SOX3 (and by analogy by SOX2) are enhancers 
rather than promoters, which is comparable to the binding pattern of SOX2 in mESCs (Chen 
et al. 2008). In fact, the comparison of SOX3 binding sites in NPCs with that of the 
transcriptional co-activator p300, which can predict active enhancers with a high accuracy 
(Visel et al. 2009), revealed that SOX3 binds a large number of enhancers that are active 
specifically in the CNS. 
Although SOX2 is expressed in NPCs, it is best known for its role in pluripotent stem cells like 
ESCs. By comparing the binding pattern of SOX2 in mESCs with that of SOX3 in NPCs, we 
found that nearly half of the genes bound by SOX2 are later bound by SOX3. Using publicly 
available expression profiles, we found that while the genes that are uniquely bound by SOX2 
in mESCs are most significantly expressed in mESCs, the genes that are sequentially targeted 
by SOX2 and SOX3 are mostly expressed in NPCs. These results show that in mESCs, SOX2 
pre-binds silent genes that will be expressed and bound by SOX3 at a subsequent 
developmental stage. However, although the binding patterns of SOX2 in mESCs and 
SOX2/SOX3 in NPCs overlap greatly, they mostly target their common genes through different 
sites. One possible explanation is that the target site selection relies on the interaction with 
distinct cell type-specific partner factors. Accordingly, SOX2 binding sites in mESCs, but not 
SOX3 (and by analogy SOX2) binding sites in NPCs, are highly enriched for OCT4 motifs. 
SOX2 in ESCs has previously been shown to bind H3K4me3 marked regulatory regions of 
active genes involved in pluripotency, as well as bivalent (H3K4me3 and H3K27me3 marked) 
regulatory regions of silent genes, which will be expressed later during development. The 
analysis of the expression pattern of the bivalent genes bound by SOX2 in ESCs revealed that 
these genes become activated in the neural lineage, but not in the endodermal and mesodermal 
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lineages. Thus, by preselecting neural genes in mESCs, SOX2 may be involved in establishing 
the competence of ESCs to develop along the neural lineage.  
In addition, a large proportion of the SOX3 bound genes are not pre-bound by SOX2 in mESCs, 
and are in fact uniquely bound by SOX3 in NPCs. These genes are most highly expressed at 
later stages of neural lineage development, in late populations of neurons and/or glial cells. 
Knowing that SOXC proteins are expressed in neurons and are important for the induction of 
neuronal characteristics, we performed SOX11 ChIP-seq experiments in mESC-derived early 
neurons, and compared the binding profile of SOX11 with that of SOX3.  
Strikingly, we found that the binding profiles of SOX3 and SOX11 overlap extensively despite 
having different functions during neural development. Indeed, 92% of the sites bound by 
SOX11 in early neurons are already bound by SOX3 in NPCs. We found that the genes that 
are sequentially bound by SOX3 and SOX11 are most significantly expressed in NPCs and 
early neurons. While the binding of SOX11 to neuronal genes can be expected, its binding to 
progenitor genes, which are silent when SOX11 is expressed, is more surprising and suggests 
that SOX11 may help turn off their expression. The genes that are uniquely bound by SOX3 
are mostly expressed in late populations of neurons and/or glial cells. Together, these results 
show that in NPCs, SOX3 preselects many silent genes that will be bound by SOX11 and 
expressed in developing neurons.  
To examine the regulatory roles of SOX3 and SOX11 on their target genes, we performed a 
number of functional experiments. First, we stably overexpressed SOX3 in ESC-derived NPCs. 
The gene expression analysis of the misregulated genes coupled with the analysis of the SOX3 
ChIP-seq data revealed that SOX3 primarily activates the NPC genes it binds to, but does 
activate the bound neuronal genes. Next, we investigated the role of SOX3 and SOX11 on 
commonly bound putative neuronal enhancers. Misexpression of SOX11 in the chicken neural 
tube as well as transactivation assays showed that SOX11 activates these enhancers. However, 
SOX3 blocks the SOX11-mediated reporter activation, and overexpression of increasing 
amounts of SOX3 in the chicken neural tube efficiently blocks the SOX11-mediated induction 
of the neuronal gene Tubb3. These findings suggest that SOX3 binds and activates enhancers 
of progenitor genes in NPCs, and also pre-binds enhancers of neuronal genes that will be 
targeted and activated by SOX11 in neurons. It is possible that the pre-binding of SOX3 on 
neuronal enhancers may prevent their precocious activation by SOX11 during the short time 
window when SOX3 and SOX11 are co-expressed in proliferative NPCs, until SOX3 is 
eventually downregulated.  
Thus, in analogy with the pre-binding of SOX2 to silent progenitor genes in ESCs, and their 
subsequent binding and activation by SOX3 in NPCs, SOX3 also pre-binds many silent 
neuronal genes that are subsequently bound and activated by SOX11 in neurons.  
This finding prompted us to examine the histone modification marks located at SOX3 and 
SOX11 bound enhancers. Using sequential ChIP-qPCR, we found that in NPCs, the SOX3-
bound enhancers associated with genes expressed in NPCs carry the H3K4me3 mark only. In 
contrast the SOX3-bound enhancers associated with silent neuronal and glial enhancers are 
marked by both H3K4me3 and H3K27me3. Upon differentiation of NPCs into neurons and 
SOX11 binding, the H3K4me3 mark associated with the previously active progenitor 
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enhancers is replaced by the H3K27me3 mark, and the bivalent mark on neuronal enhancers is 
resolved into a monovalent H3K4me3 mark as enhancers become activated. 
To test whether SOX proteins are directly involved in the deposition of histone modification 
marks, we ectopically expressed SOX3 in the mesodermal progenitor cell line C2C12. We 
observed that SOX3 promotes the accumulation of the H3K4me3 mark at its bound enhancers, 
indicating that SOX3 may alter the chromatin state locally. 
Together, these results indicate that an important role of SOXB1 proteins in NPCs is to 
maintain silent genes poised for activation by the sequentially acting SOXC protein, SOX11. 
Consistently, in mESCs, SOX2 has been shown to bind and epigenetically prepare the locus 
λ5-VpreB1 by facilitating the addition of H3K4me2 and H3K4me3 marks. Upon B cell 
differentiation, this locus is bound and activated by the SOXC protein SOX4 (Liber et al. 2010). 
In summary, these data provide evidence that SOX proteins pre-bind large sets of poised silent 
genes in ESCs and NPCs that are destined to be activated by alternative SOX proteins at later 
stages of neuronal differentiation. Here, we propose a model whereby the sequential binding 
of distinct SOX proteins to common sets of genes drives neurogenesis (Figure 4). 
Figure 4. Sequential binding of SOX proteins during neural lineage development. Model depicting the 
sequential binding of distinct SOX proteins to common genes during the differentiation of ESCs towards the 
neuronal lineage, and highlighting the association between SOX pre-binding and bivalent histone 
modification marks (Bergsland et al. 2011). 
7.2 PAPER II 
Distinct transcription factor complexes act on a permissive chromatin landscape to establish 
regionalized gene expression in CNS stem cells 
The CNS is a complex organ consisting of thousands of different neural cell types that are 
mainly produced during embryonic stages. The generation of this impressive cell diversity 
relies on the fact that NPCs at distinct spatial locations along the major axes of the developing 
embryo exhibit distinct gene expression profiles. Gene expression is largely regulated by the 
combined actions of TFs and their interacting partners on their downstream target genes. 
However, the binding of TFs is also greatly affected by the extent of chromatin accessibility 
and chromatin compaction. Here, we have used genome-wide approaches to investigate how 
these different regulatory features interact to establish specific gene expression profiles in 
NPCs from different regions of the developing mouse neural tube, the cortex (CX) and the 
spinal cord (SC). We have generated and compared DNase-seq, RNA-seq and SOX2 ChIP-seq 
data in NPCs from the E11.5 cortex and spinal cord.  
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First, we investigated how the chromatin landscape correlates with the differences in gene 
expression between NPCs of the CX and the SC. The stringent analysis of the DNase-seq 
experiments identified approximately 34,000 DHSs in each NPC population. CX and SC NPCs 
share a large number of open chromatin regions, as 75% of the DHSs are common to both cell 
types. Interestingly, the majority of these common DHSs are also present in ESCs as well as in 
endodermal and mesodermal progenitor cells. Conversely, most of DHSs specific to CX or SC 
NPCs are not shared with other stem or progenitor cells populations, and are overwhelmingly 
located distant from the closest transcription start site (TSS). These results suggest that cell 
type-specific DHSs correspond to enhancer regions that are mostly formed de novo during CNS 
development.  
By comparing the RNA-seq data of CX and SC NPCs, we identified genes that are specifically 
expressed in CX or in SC NPCs, as well as genes expressed in both cell types. The comparison 
of the chromatin accessibility data with these different sets of expressed genes revealed that 
DHSs specific to the CX are enriched around genes that are specifically expressed in the CX, 
whereas DHSs specific to the SC are enriched around genes that are specifically expressed in 
the SC. However, common DHSs are not only enriched around commonly expressed genes, 
but are also enriched around genes that are specifically expressed in CX or SC NPCs. To further 
characterize these common DHSs, we assessed the number of DHS reads in each cell type. 
Interestingly, we found that common DHSs with a higher number of reads in CX NPCs 
compared to SC NPCs were enriched for genes that are specifically expressed in CX NPCs, 
and vice versa. Hence, the number of DHS reads in a particular cell type is a better predictor 
of gene expression than simply the occurrence of a DHS. Such observation had previously been 
reported in hematopoietic cells, where a high number of reads in DHSs at TSS has been 
correlated to a strong gene expression (Boyle et al. 2008).  
Next, we investigated how differences in chromatin accessibility between CX and SC NPCs 
correlate with TF binding. All NPCs of the developing CNS express high levels of SOX2, 
which is a key regulator of NPCs. We thus performed SOX2 ChIP-seq experiments in CX and 
in SC NPCs, and found that the genome-wide binding profile of SOX2 differs quite extensively 
between the two cell types. Using our gene expression data sets and gene ontology analysis, 
we found that genes that are uniquely bound by SOX2 in the CX are most significantly 
expressed in CX NPCs, whereas genes that are exclusively bound by SOX2 in the SC are 
mostly expressed in SC NPCs. We then examined the overlap between SOX2 bound regions 
(also called peaks) and DHSs in order to study the relationship between SOX2 binding and 
chromatin accessibly. These comparisons revealed that common SOX2 peaks are found within 
regions of common DHSs. Additionally, although SOX2 specific peaks are enriched within 
specific DHSs, they are surprisingly often found within regions of common DHS. However, 
by assessing the number of DHS reads, we found a correlation between SOX2 binding and the 
extent of chromatin accessibility in CX and SC NPCs. These data suggest that the number of 
DHS reads in a particular cell type can more accurately predict TF binding than the occurrence 
of a DHS. 
SOX TF are known to interact with partner TFs not only to modulate their transcriptional 
regulatory activity, but also to refine their target site selection (Kondoh & Kamachi 2010). 
Thus, in order to better understand why DHSs that are commonly found in the CX and the SC 
are often bound by SOX2 in only one of these two cell types, we performed a DNA motif 
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analysis in CX and SC specific SOX2 peaks. This analysis revealed a strong enrichment of 
LHX2 motifs in SOX2 bound regions in the CX, and an enrichment of HOXA9 motifs in SOX2 
bound regions in the SC. In addition, the analysis of DHSs for DNase I footprints (short DNA 
sequences within a DHS that are bound by regulatory proteins and are thus resistant to DNase 
I cleavage (Galas & Schmitz 1978)) identified neighboring SOX2 LHX2 motifs in CX NPCs, 
and SOX2 HOXA9 motifs in SC NPCs. These results suggest that SOX2 binds together with 
LHX2 and HOX proteins in NPCs of the CX and the SC, respectively. 
To examine whether SOX2 bound DNA regions are involved in specifying specific gene 
expression in distinct NPC populations of the developing CNS, we used a GFP-reporter assay 
in zebrafish embryos allowing the visualization of the spatial distribution of enhancer activity 
in vivo. We found that the regions bound by SOX2 function as enhancers capable of driving 
reporter gene expression, and are activated in a spatially restricted fashion. Indeed, while DNA 
regions commonly bound by SOX2 in the CX and SC activate GFP expression along the entire 
A/P axis of the developing CNS, regions specifically bound by SOX2 in the CX exclusively 
activate reporter gene expression in the brain, and the reverse is true for regions specifically 
bound by SOX2 in the SC. Moreover, loss-of-function experiments, by mutating SOX motifs 
or injecting morpholinos against SOX2 and SOX3, indicate that SOX2 is necessary for the 
activation of the majority of the enhancers tested. Additionally, the mutations of LHX motifs 
in CX enhancers, and of HOX motifs (together with PBX and MEIS, two known partners of 
HOX proteins (Shanmugam et al. 1999)) in SC enhancers, result in the loss of enhancer activity. 
This suggests that these motifs are necessary for enhancer activation, and that the proteins 
binding to these motifs may function as SOX2 partners. Furthermore, interchanging HOX and 
LHX motifs between CX and SC enhancers is sufficient to re-specify the spatial distribution of 
the enhancers. Indeed, “swapped” SC enhancers are now activated in the brain and vice versa. 
Finally, we created enhancers in which all the nucleotides are randomized, except for SOX, 
LHX and HOX motifs (as well as PBX and MEIS motifs). These “synthetic” enhancers are 
able to activate reporter gene expression, although at lower levels compared to wild type 
enhancers. Taken together, these experiments demonstrate that SOX, LHX and HOX motifs 
(as well as PBX and MEIS motifs) are necessary and sufficient to confer cell type-specific 
enhancer activity. Consistent with these results, immunoprecipitation experiments as well as 
transactivation assays indicate that SOX2 and LHX2 can physically interact, at least in vitro, 
and cooperate to activate CX specific enhancers, whereas SOX2 and HOXB6 (together with 
PBX3 and MEIS1) can interact and cooperate to activate SC specific enhancers. 
Our findings indicate that SOX2 often targets DNA in a cell type-specific manner although the 
DNA is accessible in both CX and SC NPCs. Moreover, our data further indicate that the cell 
type-specific binding pattern of SOX2, within a permissive chromatin landscape, can be 
explained by the region-specific distribution of SOX2 partner factors, LHX2 and HOX 
proteins. We next wanted to examine whether the misexpression of HOXB6 protein in CX 
NPCs could induce ectopic expression of SC genes in CX NPCs. To address this question, we 
performed in utero electroporation on E13.5 mouse cortices, followed by fluorescent-activated 
cell sorting (FACS) and RNA-seq. The misexpression of HOXB6 induces the upregulation of 
many SC expressed genes and the downregulation of many CX expressed genes. We then 
further analyzed these genes by characterizing their DHSs and SOX2 binding profiles, as well 
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as their enrichment for HOX motifs. We found that the upregulated SC genes are often 
associated with DHSs, bound by SOX2 in both CX and SC NPCs, and enriched in HOX motifs.  
Finally, we used our DNase-seq, SOX2 ChIP-seq and RNA-seq data sets to generate a 
hierarchical statistical model in order to explain gene expression differences between CX and 
SC NPCs. This model reveals that the number of DHS reads is the best predictor of gene 
expression specificity in NPCs from different regions of the developing CNS. Moreover, the 
number of DHS reads is influenced by the relative SOX2 binding, which is in turn predicted 
by HOX and LHX motifs enrichment.  
In this study, we have shown that despite being ubiquitously expressed in NPCs of the 
developing CNS, SOX2 acts on a permissive chromatin landscape to establish distinct gene 
expression patterns in NPCs from different regions of the developing CNS. The differences in 
SOX2 binding pattern between CX and SC NPCs can primarily be explained by its interaction 
with distinct partner factors, rather than by variations in the degree of chromatin accessibility. 
7.3 PAPER III 
scRNA-seq and ChIP-seq analyses in glial progenitors reveal extensive SOX9 pre-binding 
to astrocyte and oligodendrocyte specific genes 
The vertebrate CNS is composed of three major cell types, namely neurons, astrocytes and 
oligodendrocytes that are generated in a temporal sequence by multipotent NPCs during 
development. In Paper I, we have shown that SOX3 activates the expression of NPCs genes 
and pre-binds many silent neuronal genes that are first activated in differentiated neurons when 
SOX3 is downregulated and replaced by SOX11. However, due to the lack of specific gene 
expression profiles for developing astrocytes and oligodendrocytes, it is not clear whether 
genes exclusively expressed in astrocytes and oligodendrocytes are pre-bound by SOX proteins 
prior to their activation, and whether these genes are later bound and activated by alternative 
lineage-specific SOX proteins. Thus, in order to investigate how neuronal and glial gene 
expression programs are activated in a lineage-specific and timely manner, we have used single 
cell RNA-sequencing (scRNA-seq) to determine the specific expression profiles of mouse 
spinal cord progenitor cells and their neuronal and glial progeny. Additionally, we have 
performed ChIP-seq in order to characterize the genome-wide binding profiles of SOX3 and 
SOX9 in mESCs-derived glial progenitor cells (GPCs).  
We first performed scRNA-seq on NPCs isolated from the mouse embryonic spinal cord at 
E11.5, prior to the onset of gliogenesis, and on E15.5 cells corresponding to a mixture of 
progenitors, neurons and glial cells. Using advanced bioinformatics tools, the transcriptome 
analysis of 350 cells defined 7 distinct cell clusters. The differential expression analysis 
performed on the different clusters identified gene expression signatures (containing hundreds 
of differentially expressed genes) specific of each cluster, with the exception of one cluster that 
was excluded from further analysis due to the low number of differentially expressed genes. 
Gene ontology analysis of the distinct gene expression signatures resulted in the identification 
of the 6 remaining cell clusters, which correspond to NPCs, neurons, astrocytes, 
oligodendrocytes, as well as microglia and mesodermal cells. The gene signature of each 
cluster includes well-known genes characteristic of each cell type, such as Map2 and Stmn2 in 
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the neuronal cluster, Fgfbp3 and Slc1a3 (GLAST) in the astrocyte cluster, and Mpb and Sox10 
in the oligodendrocyte cluster, which further confirms their identity.  
The analysis of the SOX3 ChIP-seq data in mESC-derived NPCs (from Paper I) coupled with 
the aforementioned specific gene expression profiles, revealed that in addition to neuronal 
genes, approximately 40% of the astrocyte and of the oligodendrocyte specific genes are 
already bound by SOX3 in NPCs. These results indicate that in NPCs, a cell population that is 
competent to give rise to neurons rather than glial cells, SOX3 pre-binds silent genes of all 
three neural lineages. Considering that SOX3 is expressed in both astrocyte and 
oligodendrocyte progenitor cells, we determined its binding profile in progenitor cells which 
are competent to give rise to glial cells. To this aim, we differentiated mESCs to sequentially 
generate NPCs and GPCs, and we performed a SOX3 ChIP-seq in GPCs. In this in vitro 
context, it is important to note the same pool of GPCs gives rise to both astrocytes and 
oligodendrocytes, whereas in vivo, astrocytes and oligodendrocytes of the developing spinal 
cord are generated by different populations of progenitor cells residing in distinct progenitor 
domains. 
By comparing the binding patterns of SOX3 in NPCs and GPCs, we found that 30% of SOX3 
binding sites in GPCs are already occupied in NPCs, indicating that SOX3 targets many new 
sites in GPCs.  Hence, in a similar way to the changing binding pattern of SOX2 between ESCs 
and NPCs (Paper I), SOX3 also changes binding sites in the transition from NPCs to GPCs, 
which is likely due to their interaction with changing partner factors. Interestingly, while genes 
from all lineages are bound by SOX3 in NPCs, astrocyte specific genes are particularly 
enriched among the SOX3 targets in GPCs.  
Next, we examined the epigenetic state of SOX3 bound enhancers in NPCs. To do this, we 
performed ChIP-seq experiments to identify enhancer regions associated with the H3K27ac 
mark in NPCs and in GPCs, a histone modification mark associated with active enhancers 
(Creyghton et al. 2010). The mapping of H3K27ac reads to SOX3 bound regions in NPCs 
defined two types of SOX3 bound enhancers in NPCs. First, the enhancers carrying the active 
H3K27ac mark in NPCs and that continue to carry this mark in GPCs. These enhancers are 
associated to genes that are primarily expressed in astrocytes. Second, the enhancers that are 
marked with H3K27ac in NPCs but that are no longer marked in GPCs. In contrast, these 
enhancers are associated to genes that are primarily expressed in NPCs, neurons, and 
oligodendrocytes. Taken together, these results show that genes of all lineages are associated 
to H3K27ac marked enhancers that are pre-bound by SOX3 in NPCs. On the other hand, 
astrocyte genes are associated with enhancers that maintain the H3K27ac mark and are 
especially enriched among the SOX3 targets in GPCs. 
Another SOX protein, SOX9, which is co-expressed with SOX3, starts to be expressed in 
progenitor cells just before they commit to generate glial cell types, and has been demonstrated 
to have a key role in the neuron to glia switch (Stolt et al. 2003). SOX9 continues to be 
expressed in differentiating astrocytes until adulthood, whereas it is transiently expressed in 
differentiating oligodendrocytes. To better understand the role of SOX9 during gliogenesis, we 
performed ChIP-seq experiments in GPCs and compared the genome-wide binding profile of 
SOX9 to that of SOX3 in GPCs. We found that 25% of SOX3 binding sites are also bound by 
SOX9 in GPCs, and that astrocyte genes are highly enriched among the genes targeted by both 
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SOX3 and SOX9 in GPCs. Therefore, astrocytes genes are characterized by the continuous 
binding of SOX3 and the concomitant binding of SOX9 in GPCs. Additionally, we found that 
although oligodendrocytes genes are already bound by SOX3 in NPCs, SOX3 binding does not 
appear to be maintained on oligodendrocyte genes in GPCs.  
In contrast to astrocyte genes, oligodendrocyte genes are preferentially bound by SOX9 only 
in GPCs, and not by SOX3. While SOX9 is expressed in both astrocytes and oligodendrocytes, 
SOX10 is specifically expressed in oligodendrocytes and is essential for their terminal 
termination (Stolt et al. 2002). In order to better understand how the oligodendrocyte lineage 
is regulated, we have compared the published SOX10 ChIP-seq data from mature 
oligodendrocytes (Lopez-Anido et al. 2015) to the SOX9 ChIP-seq data in GPCs. We found 
that the oligodendrocytes genes that are highly enriched among SOX9 targets in GPCs are later 
bound by SOX10 in mature oligodendrocytes. Surprisingly, we found that astrocyte genes are 
also enriched among genes targeted by both SOX9 and SOX10. One possibility is that in 
addition to regulating oligodendrocyte genes, SOX10 may help keep the expression of 
astrocyte genes turned off during oligodendrocyte differentiation.  
In GPCs, SOX9 pre-binds, together with SOX3, astrocytes genes. SOX9 also pre-binds 
oligodendrocyte genes, many of which will later be bound by SOX10 in differentiated 
oligodendrocytes. To better understand how gene target selection is achieved in the glial two 
lineages, we examined SOX bound DNA regions and looked for enriched DNA motifs. In the 
DNA regions associated to astrocyte specific genes that are commonly bound by SOX3 and 
SOX9 in GPCs, we found that the NFI TF binding motif is highly enriched. In addition, 
transactivation assays revealed that SOX9 and NFIA can synergistically activate putative 
astrocyte enhancers, which is consistent with the fact that SOX9 has been shown to physically 
interact with NFIA during astrocyte development (Kang et al. 2012). However, NFIA is already 
expressed in GPCs together with SOX9, raising the question of why astrocyte genes are first 
activated in differentiating astrocytes. Interestingly, transactivation assays further revealed that 
SOX3 blocks the SOX9-mediated activation of putative astrocyte enhancers. Thus, one 
possibility is that the binding of SOX3 to astrocyte enhancers in GPCs prevents the premature 
activation of astrocyte genes in GPCs. 
In summary, we have shown that SOX3 pre-binds genes of both neuronal and glial lineages in 
NPCs. SOX3 binding becomes more restricted towards the astrocyte lineage in GPCs, where 
it appears to prevent the precocious activation of astrocyte genes that are instead activated by 
SOX9 and NFIA. Conversely, SOX3 does not maintain its binding to oligodendrocyte genes 
in GPCs. Instead, oligodendrocyte genes in GPCs are preferentially bound by SOX9 alone, and 
many of these genes are also bound by SOX10 in mature oligodendrocytes. Additionally, 
SOX10 binds many astrocyte specific genes in oligodendrocytes, possibly to prevent their 
expression. Collectively, these results indicate that activating or repressing SOX TFs control 
glial gene expression programs during mouse spinal cord development.  
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8 CONCLUDING REMARKS AND PERSPECTIVES 
The proper development of the CNS relies on the capacity of NPCs to generate neurons, 
astrocytes and oligodendrocytes. The decision of a NPC to self-renew or differentiate is guided 
by transcription factors. Many members of the SOX family of transcription factors are well 
known regulators of CNS development and have been shown to be involved in diverse 
processes, including NPC maintenance, cell specification and differentiation. Many insights 
into the roles of SOX TFs have come from functional studies. Owing to the advent of next-
generation sequencing approaches, many studies, including ours, have started to unravel the 
molecular mechanisms by which SOX proteins achieve their distinct functional roles. The work 
presented in this thesis was aimed to provide a better understanding of the multiple mechanisms 
employed by SOX TFs to regulate NPCs maintenance and differentiation during embryonic 
development. 
In Paper I, we have investigated the roles of SOX2, SOX3 and SOX11 during neuronal lineage 
progression by characterizing the activities of these distinct SOX proteins on their downstream 
target genes. In this study, we have provided evidence that different SOX proteins act 
sequentially to regulate gene expression during neurogenesis. Importantly, our findings add to 
the growing body of evidence suggesting that SOX proteins exhibit some features of pioneer 
factors. We have demonstrated that SOX binding precedes gene activation, as SOX2 and SOX3 
preselect silent genes that are destined to be activated by an alternative SOX protein at a later 
stage of neuronal development. Additionally, we have shown that this sequential binding is 
accompanied by changes in chromatin modifications, and that SOX3 is able to impact the 
epigenetic landscape. Moreover, the identification of cell type-specific TFs that interact with 
the distinct SOX proteins is essential to provide a better understanding of the mechanisms 
governing SOX target site selection. In this study we have identified a number of DNA binding 
motifs that are differentially enriched within SOX2, SOX3 and SOX11 targeted DNA regions. 
However, further studies will be necessary to determine the identity of the SOX partner factors 
binding these motifs during neuronal development. Moreover, it would be interesting to 
investigate if gene expression in other lineages is also controlled by sequentially pre-binding 
and activating TFs.  
Furthermore, our data raises the question of whether a sequential binding of SOX proteins also 
occurs in the glial lineage. In Paper III, we have addressed this question and found that SOX3 
already pre-binds astrocyte and oligodendrocyte genes in NPCs. In GPCs, SOX3 preferentially 
pre-binds astrocyte genes, possibly to prevent their premature expression. Our data also suggest 
that SOX9 pre-binds astrocyte specific genes together with the putative partner factor NFIA. 
SOX9 additionally pre-binds oligodendrocyte specific genes, many of which are bound by 
SOX10 in mature oligodendrocytes. To further examine the role of NFIA as a potential partner 
factor, it would be interesting to determine its binding profile in GPCs and compare it to the 
biding profile of SOX9. Moreover, in this study we have used scRNA-seq in order to 
characterize the expression profiles of the neuronal and glial cell types in the mouse embryonic 
spinal cord. The determination of gene sets specific of each cell type can be very valuable for 
the scientific community. As an example, the identification of specific markers can be used for 
the generation of conditional knock out animals.  
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In Paper II, we have examined how the interaction between chromatin accessibility and TF 
binding regulates the establishment of specific gene expression programs in NPCs from 
different regions of the developing CNS, the cortex and the spinal cord. This study reveals that 
despite being expressed in all NPCs of the developing CNS, SOX2 regulates the establishment 
of spatially distinct gene expression programs by interacting with region-specific partner 
factors on a permissive chromatin landscape. In addition, we have used this data to generate a 
model that attempts to predict gene expression differences in regionally distinct NPCs. It would 
be interesting to test the robustness of our statistical model by attempting to predict specific 
gene expression in other stem cells populations. 
The generation of a complex organ such as the CNS requires the generation of the right type 
of cells at the right place and time. The finding that SOX2 binding differs extensively between 
NPCs of distinct spatial location raises the question of whether the binding of SOX2 would 
also differ in NPCs from different developmental stages. One interesting experiment would be 
to test whether our model would also be able to predict gene expression differences in NPCs 
over time. 
Lastly, in addition to their prominent roles during the formation of the CNS, SOX proteins are 
essential to the development of most tissues and organs. As a result, mutations in SOX genes 
have been linked with a number of human diseases. For instance, mutations of SOX2 cause 
anophtalmia, SOX3 mutations are associated with X-linked mental retardation, and SOX10 
mutations are implicated in the Waardenburg-Hirschsprung syndrome. Furthermore, it is 
becoming increasingly clear that cancers can originate from adult stem cell populations, and 
that TFs important for the maintenance of normal stem cells are likely to play a significant role 
in tumor initiation and development. Many SOX proteins have indeed been found to be 
overexpressed in various types of tumors (Dong et al. 2004; Kiefer 2007; Chew & Gallo 2009). 
This highlights the importance of investigating the role of SOX proteins in relation to 
development and disease. 
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